Eprosartan Mesylate Market, Global Outlook and Forecast 2022-2028
![](/report_cover/11201/eprosartan-mesylate-market-global-outlook-n-forecast-2022-2028_en.gif)
This report contains market size and forecasts of Eprosartan Mesylate in global, including the following market information:
Global Eprosartan Mesylate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Eprosartan Mesylate Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Eprosartan Mesylate companies in 2021 (%)
The global Eprosartan Mesylate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
200mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Eprosartan Mesylate include Abbott, Viatris (Mylan), The United States Pharmacopeial Convention, Unichem Laboratories and Jubilant Generics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Eprosartan Mesylate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Eprosartan Mesylate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Eprosartan Mesylate Market Segment Percentages, by Type, 2021 (%)
Global Eprosartan Mesylate Market Segment Percentages, by Application, 2021 (%)
Global Eprosartan Mesylate Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Eprosartan Mesylate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Eprosartan Mesylate revenues share in global market, 2021 (%)
Key companies Eprosartan Mesylate sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Eprosartan Mesylate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Eprosartan Mesylate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Eprosartan Mesylate Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Eprosartan Mesylate companies in 2021 (%)
The global Eprosartan Mesylate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
200mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Eprosartan Mesylate include Abbott, Viatris (Mylan), The United States Pharmacopeial Convention, Unichem Laboratories and Jubilant Generics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Eprosartan Mesylate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Eprosartan Mesylate Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Eprosartan Mesylate Market Segment Percentages, by Type, 2021 (%)
- 200mg
- 400mg
Global Eprosartan Mesylate Market Segment Percentages, by Application, 2021 (%)
- Hypertension Diagnosis
- Heart Failure Diagnosis
- Others
Global Eprosartan Mesylate Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Eprosartan Mesylate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Eprosartan Mesylate revenues share in global market, 2021 (%)
Key companies Eprosartan Mesylate sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Eprosartan Mesylate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott
- Viatris (Mylan)
- The United States Pharmacopeial Convention
- Unichem Laboratories
- Jubilant Generics
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Eprosartan Mesylate Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Eprosartan Mesylate Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL EPROSARTAN MESYLATE OVERALL MARKET SIZE
2.1 Global Eprosartan Mesylate Market Size: 2021 VS 2028
2.2 Global Eprosartan Mesylate Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Eprosartan Mesylate Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Eprosartan Mesylate Players in Global Market
3.2 Top Global Eprosartan Mesylate Companies Ranked by Revenue
3.3 Global Eprosartan Mesylate Revenue by Companies
3.4 Global Eprosartan Mesylate Sales by Companies
3.5 Global Eprosartan Mesylate Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Eprosartan Mesylate Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Eprosartan Mesylate Product Type
3.8 Tier 1, Tier 2 and Tier 3 Eprosartan Mesylate Players in Global Market
3.8.1 List of Global Tier 1 Eprosartan Mesylate Companies
3.8.2 List of Global Tier 2 and Tier 3 Eprosartan Mesylate Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Eprosartan Mesylate Market Size Markets, 2021 & 2028
4.1.2 200mg
4.1.3 400mg
4.2 By Type - Global Eprosartan Mesylate Revenue & Forecasts
4.2.1 By Type - Global Eprosartan Mesylate Revenue, 2017-2022
4.2.2 By Type - Global Eprosartan Mesylate Revenue, 2023-2028
4.2.3 By Type - Global Eprosartan Mesylate Revenue Market Share, 2017-2028
4.3 By Type - Global Eprosartan Mesylate Sales & Forecasts
4.3.1 By Type - Global Eprosartan Mesylate Sales, 2017-2022
4.3.2 By Type - Global Eprosartan Mesylate Sales, 2023-2028
4.3.3 By Type - Global Eprosartan Mesylate Sales Market Share, 2017-2028
4.4 By Type - Global Eprosartan Mesylate Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Eprosartan Mesylate Market Size, 2021 & 2028
5.1.2 Hypertension Diagnosis
5.1.3 Heart Failure Diagnosis
5.1.4 Others
5.2 By Application - Global Eprosartan Mesylate Revenue & Forecasts
5.2.1 By Application - Global Eprosartan Mesylate Revenue, 2017-2022
5.2.2 By Application - Global Eprosartan Mesylate Revenue, 2023-2028
5.2.3 By Application - Global Eprosartan Mesylate Revenue Market Share, 2017-2028
5.3 By Application - Global Eprosartan Mesylate Sales & Forecasts
5.3.1 By Application - Global Eprosartan Mesylate Sales, 2017-2022
5.3.2 By Application - Global Eprosartan Mesylate Sales, 2023-2028
5.3.3 By Application - Global Eprosartan Mesylate Sales Market Share, 2017-2028
5.4 By Application - Global Eprosartan Mesylate Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Eprosartan Mesylate Market Size, 2021 & 2028
6.2 By Region - Global Eprosartan Mesylate Revenue & Forecasts
6.2.1 By Region - Global Eprosartan Mesylate Revenue, 2017-2022
6.2.2 By Region - Global Eprosartan Mesylate Revenue, 2023-2028
6.2.3 By Region - Global Eprosartan Mesylate Revenue Market Share, 2017-2028
6.3 By Region - Global Eprosartan Mesylate Sales & Forecasts
6.3.1 By Region - Global Eprosartan Mesylate Sales, 2017-2022
6.3.2 By Region - Global Eprosartan Mesylate Sales, 2023-2028
6.3.3 By Region - Global Eprosartan Mesylate Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Eprosartan Mesylate Revenue, 2017-2028
6.4.2 By Country - North America Eprosartan Mesylate Sales, 2017-2028
6.4.3 US Eprosartan Mesylate Market Size, 2017-2028
6.4.4 Canada Eprosartan Mesylate Market Size, 2017-2028
6.4.5 Mexico Eprosartan Mesylate Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Eprosartan Mesylate Revenue, 2017-2028
6.5.2 By Country - Europe Eprosartan Mesylate Sales, 2017-2028
6.5.3 Germany Eprosartan Mesylate Market Size, 2017-2028
6.5.4 France Eprosartan Mesylate Market Size, 2017-2028
6.5.5 U.K. Eprosartan Mesylate Market Size, 2017-2028
6.5.6 Italy Eprosartan Mesylate Market Size, 2017-2028
6.5.7 Russia Eprosartan Mesylate Market Size, 2017-2028
6.5.8 Nordic Countries Eprosartan Mesylate Market Size, 2017-2028
6.5.9 Benelux Eprosartan Mesylate Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Eprosartan Mesylate Revenue, 2017-2028
6.6.2 By Region - Asia Eprosartan Mesylate Sales, 2017-2028
6.6.3 China Eprosartan Mesylate Market Size, 2017-2028
6.6.4 Japan Eprosartan Mesylate Market Size, 2017-2028
6.6.5 South Korea Eprosartan Mesylate Market Size, 2017-2028
6.6.6 Southeast Asia Eprosartan Mesylate Market Size, 2017-2028
6.6.7 India Eprosartan Mesylate Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Eprosartan Mesylate Revenue, 2017-2028
6.7.2 By Country - South America Eprosartan Mesylate Sales, 2017-2028
6.7.3 Brazil Eprosartan Mesylate Market Size, 2017-2028
6.7.4 Argentina Eprosartan Mesylate Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Eprosartan Mesylate Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Eprosartan Mesylate Sales, 2017-2028
6.8.3 Turkey Eprosartan Mesylate Market Size, 2017-2028
6.8.4 Israel Eprosartan Mesylate Market Size, 2017-2028
6.8.5 Saudi Arabia Eprosartan Mesylate Market Size, 2017-2028
6.8.6 UAE Eprosartan Mesylate Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Eprosartan Mesylate Major Product Offerings
7.1.4 Abbott Eprosartan Mesylate Sales and Revenue in Global (2017-2022)
7.1.5 Abbott Key News
7.2 Viatris (Mylan)
7.2.1 Viatris (Mylan) Corporate Summary
7.2.2 Viatris (Mylan) Business Overview
7.2.3 Viatris (Mylan) Eprosartan Mesylate Major Product Offerings
7.2.4 Viatris (Mylan) Eprosartan Mesylate Sales and Revenue in Global (2017-2022)
7.2.5 Viatris (Mylan) Key News
7.3 The United States Pharmacopeial Convention
7.3.1 The United States Pharmacopeial Convention Corporate Summary
7.3.2 The United States Pharmacopeial Convention Business Overview
7.3.3 The United States Pharmacopeial Convention Eprosartan Mesylate Major Product Offerings
7.3.4 The United States Pharmacopeial Convention Eprosartan Mesylate Sales and Revenue in Global (2017-2022)
7.3.5 The United States Pharmacopeial Convention Key News
7.4 Unichem Laboratories
7.4.1 Unichem Laboratories Corporate Summary
7.4.2 Unichem Laboratories Business Overview
7.4.3 Unichem Laboratories Eprosartan Mesylate Major Product Offerings
7.4.4 Unichem Laboratories Eprosartan Mesylate Sales and Revenue in Global (2017-2022)
7.4.5 Unichem Laboratories Key News
7.5 Jubilant Generics
7.5.1 Jubilant Generics Corporate Summary
7.5.2 Jubilant Generics Business Overview
7.5.3 Jubilant Generics Eprosartan Mesylate Major Product Offerings
7.5.4 Jubilant Generics Eprosartan Mesylate Sales and Revenue in Global (2017-2022)
7.5.5 Jubilant Generics Key News
8 GLOBAL EPROSARTAN MESYLATE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Eprosartan Mesylate Production Capacity, 2017-2028
8.2 Eprosartan Mesylate Production Capacity of Key Manufacturers in Global Market
8.3 Global Eprosartan Mesylate Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 EPROSARTAN MESYLATE SUPPLY CHAIN ANALYSIS
10.1 Eprosartan Mesylate Industry Value Chain
10.2 Eprosartan Mesylate Upstream Market
10.3 Eprosartan Mesylate Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Eprosartan Mesylate Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Eprosartan Mesylate Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Eprosartan Mesylate Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL EPROSARTAN MESYLATE OVERALL MARKET SIZE
2.1 Global Eprosartan Mesylate Market Size: 2021 VS 2028
2.2 Global Eprosartan Mesylate Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Eprosartan Mesylate Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Eprosartan Mesylate Players in Global Market
3.2 Top Global Eprosartan Mesylate Companies Ranked by Revenue
3.3 Global Eprosartan Mesylate Revenue by Companies
3.4 Global Eprosartan Mesylate Sales by Companies
3.5 Global Eprosartan Mesylate Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Eprosartan Mesylate Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Eprosartan Mesylate Product Type
3.8 Tier 1, Tier 2 and Tier 3 Eprosartan Mesylate Players in Global Market
3.8.1 List of Global Tier 1 Eprosartan Mesylate Companies
3.8.2 List of Global Tier 2 and Tier 3 Eprosartan Mesylate Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Eprosartan Mesylate Market Size Markets, 2021 & 2028
4.1.2 200mg
4.1.3 400mg
4.2 By Type - Global Eprosartan Mesylate Revenue & Forecasts
4.2.1 By Type - Global Eprosartan Mesylate Revenue, 2017-2022
4.2.2 By Type - Global Eprosartan Mesylate Revenue, 2023-2028
4.2.3 By Type - Global Eprosartan Mesylate Revenue Market Share, 2017-2028
4.3 By Type - Global Eprosartan Mesylate Sales & Forecasts
4.3.1 By Type - Global Eprosartan Mesylate Sales, 2017-2022
4.3.2 By Type - Global Eprosartan Mesylate Sales, 2023-2028
4.3.3 By Type - Global Eprosartan Mesylate Sales Market Share, 2017-2028
4.4 By Type - Global Eprosartan Mesylate Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Eprosartan Mesylate Market Size, 2021 & 2028
5.1.2 Hypertension Diagnosis
5.1.3 Heart Failure Diagnosis
5.1.4 Others
5.2 By Application - Global Eprosartan Mesylate Revenue & Forecasts
5.2.1 By Application - Global Eprosartan Mesylate Revenue, 2017-2022
5.2.2 By Application - Global Eprosartan Mesylate Revenue, 2023-2028
5.2.3 By Application - Global Eprosartan Mesylate Revenue Market Share, 2017-2028
5.3 By Application - Global Eprosartan Mesylate Sales & Forecasts
5.3.1 By Application - Global Eprosartan Mesylate Sales, 2017-2022
5.3.2 By Application - Global Eprosartan Mesylate Sales, 2023-2028
5.3.3 By Application - Global Eprosartan Mesylate Sales Market Share, 2017-2028
5.4 By Application - Global Eprosartan Mesylate Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Eprosartan Mesylate Market Size, 2021 & 2028
6.2 By Region - Global Eprosartan Mesylate Revenue & Forecasts
6.2.1 By Region - Global Eprosartan Mesylate Revenue, 2017-2022
6.2.2 By Region - Global Eprosartan Mesylate Revenue, 2023-2028
6.2.3 By Region - Global Eprosartan Mesylate Revenue Market Share, 2017-2028
6.3 By Region - Global Eprosartan Mesylate Sales & Forecasts
6.3.1 By Region - Global Eprosartan Mesylate Sales, 2017-2022
6.3.2 By Region - Global Eprosartan Mesylate Sales, 2023-2028
6.3.3 By Region - Global Eprosartan Mesylate Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Eprosartan Mesylate Revenue, 2017-2028
6.4.2 By Country - North America Eprosartan Mesylate Sales, 2017-2028
6.4.3 US Eprosartan Mesylate Market Size, 2017-2028
6.4.4 Canada Eprosartan Mesylate Market Size, 2017-2028
6.4.5 Mexico Eprosartan Mesylate Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Eprosartan Mesylate Revenue, 2017-2028
6.5.2 By Country - Europe Eprosartan Mesylate Sales, 2017-2028
6.5.3 Germany Eprosartan Mesylate Market Size, 2017-2028
6.5.4 France Eprosartan Mesylate Market Size, 2017-2028
6.5.5 U.K. Eprosartan Mesylate Market Size, 2017-2028
6.5.6 Italy Eprosartan Mesylate Market Size, 2017-2028
6.5.7 Russia Eprosartan Mesylate Market Size, 2017-2028
6.5.8 Nordic Countries Eprosartan Mesylate Market Size, 2017-2028
6.5.9 Benelux Eprosartan Mesylate Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Eprosartan Mesylate Revenue, 2017-2028
6.6.2 By Region - Asia Eprosartan Mesylate Sales, 2017-2028
6.6.3 China Eprosartan Mesylate Market Size, 2017-2028
6.6.4 Japan Eprosartan Mesylate Market Size, 2017-2028
6.6.5 South Korea Eprosartan Mesylate Market Size, 2017-2028
6.6.6 Southeast Asia Eprosartan Mesylate Market Size, 2017-2028
6.6.7 India Eprosartan Mesylate Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Eprosartan Mesylate Revenue, 2017-2028
6.7.2 By Country - South America Eprosartan Mesylate Sales, 2017-2028
6.7.3 Brazil Eprosartan Mesylate Market Size, 2017-2028
6.7.4 Argentina Eprosartan Mesylate Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Eprosartan Mesylate Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Eprosartan Mesylate Sales, 2017-2028
6.8.3 Turkey Eprosartan Mesylate Market Size, 2017-2028
6.8.4 Israel Eprosartan Mesylate Market Size, 2017-2028
6.8.5 Saudi Arabia Eprosartan Mesylate Market Size, 2017-2028
6.8.6 UAE Eprosartan Mesylate Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Eprosartan Mesylate Major Product Offerings
7.1.4 Abbott Eprosartan Mesylate Sales and Revenue in Global (2017-2022)
7.1.5 Abbott Key News
7.2 Viatris (Mylan)
7.2.1 Viatris (Mylan) Corporate Summary
7.2.2 Viatris (Mylan) Business Overview
7.2.3 Viatris (Mylan) Eprosartan Mesylate Major Product Offerings
7.2.4 Viatris (Mylan) Eprosartan Mesylate Sales and Revenue in Global (2017-2022)
7.2.5 Viatris (Mylan) Key News
7.3 The United States Pharmacopeial Convention
7.3.1 The United States Pharmacopeial Convention Corporate Summary
7.3.2 The United States Pharmacopeial Convention Business Overview
7.3.3 The United States Pharmacopeial Convention Eprosartan Mesylate Major Product Offerings
7.3.4 The United States Pharmacopeial Convention Eprosartan Mesylate Sales and Revenue in Global (2017-2022)
7.3.5 The United States Pharmacopeial Convention Key News
7.4 Unichem Laboratories
7.4.1 Unichem Laboratories Corporate Summary
7.4.2 Unichem Laboratories Business Overview
7.4.3 Unichem Laboratories Eprosartan Mesylate Major Product Offerings
7.4.4 Unichem Laboratories Eprosartan Mesylate Sales and Revenue in Global (2017-2022)
7.4.5 Unichem Laboratories Key News
7.5 Jubilant Generics
7.5.1 Jubilant Generics Corporate Summary
7.5.2 Jubilant Generics Business Overview
7.5.3 Jubilant Generics Eprosartan Mesylate Major Product Offerings
7.5.4 Jubilant Generics Eprosartan Mesylate Sales and Revenue in Global (2017-2022)
7.5.5 Jubilant Generics Key News
8 GLOBAL EPROSARTAN MESYLATE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Eprosartan Mesylate Production Capacity, 2017-2028
8.2 Eprosartan Mesylate Production Capacity of Key Manufacturers in Global Market
8.3 Global Eprosartan Mesylate Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 EPROSARTAN MESYLATE SUPPLY CHAIN ANALYSIS
10.1 Eprosartan Mesylate Industry Value Chain
10.2 Eprosartan Mesylate Upstream Market
10.3 Eprosartan Mesylate Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Eprosartan Mesylate Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Eprosartan Mesylate in Global Market
Table 2. Top Eprosartan Mesylate Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Eprosartan Mesylate Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Eprosartan Mesylate Revenue Share by Companies, 2017-2022
Table 5. Global Eprosartan Mesylate Sales by Companies, (Tons), 2017-2022
Table 6. Global Eprosartan Mesylate Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Eprosartan Mesylate Price (2017-2022) & (US$/Ton)
Table 8. Global Manufacturers Eprosartan Mesylate Product Type
Table 9. List of Global Tier 1 Eprosartan Mesylate Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Eprosartan Mesylate Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Eprosartan Mesylate Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Eprosartan Mesylate Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Eprosartan Mesylate Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Eprosartan Mesylate Sales (Tons), 2017-2022
Table 15. By Type - Global Eprosartan Mesylate Sales (Tons), 2023-2028
Table 16. By Application – Global Eprosartan Mesylate Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Eprosartan Mesylate Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Eprosartan Mesylate Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Eprosartan Mesylate Sales (Tons), 2017-2022
Table 20. By Application - Global Eprosartan Mesylate Sales (Tons), 2023-2028
Table 21. By Region – Global Eprosartan Mesylate Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Eprosartan Mesylate Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Eprosartan Mesylate Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Eprosartan Mesylate Sales (Tons), 2017-2022
Table 25. By Region - Global Eprosartan Mesylate Sales (Tons), 2023-2028
Table 26. By Country - North America Eprosartan Mesylate Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Eprosartan Mesylate Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Eprosartan Mesylate Sales, (Tons), 2017-2022
Table 29. By Country - North America Eprosartan Mesylate Sales, (Tons), 2023-2028
Table 30. By Country - Europe Eprosartan Mesylate Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Eprosartan Mesylate Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Eprosartan Mesylate Sales, (Tons), 2017-2022
Table 33. By Country - Europe Eprosartan Mesylate Sales, (Tons), 2023-2028
Table 34. By Region - Asia Eprosartan Mesylate Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Eprosartan Mesylate Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Eprosartan Mesylate Sales, (Tons), 2017-2022
Table 37. By Region - Asia Eprosartan Mesylate Sales, (Tons), 2023-2028
Table 38. By Country - South America Eprosartan Mesylate Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Eprosartan Mesylate Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Eprosartan Mesylate Sales, (Tons), 2017-2022
Table 41. By Country - South America Eprosartan Mesylate Sales, (Tons), 2023-2028
Table 42. By Country - Middle East & Africa Eprosartan Mesylate Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Eprosartan Mesylate Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Eprosartan Mesylate Sales, (Tons), 2017-2022
Table 45. By Country - Middle East & Africa Eprosartan Mesylate Sales, (Tons), 2023-2028
Table 46. Abbott Corporate Summary
Table 47. Abbott Eprosartan Mesylate Product Offerings
Table 48. Abbott Eprosartan Mesylate Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 49. Viatris (Mylan) Corporate Summary
Table 50. Viatris (Mylan) Eprosartan Mesylate Product Offerings
Table 51. Viatris (Mylan) Eprosartan Mesylate Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 52. The United States Pharmacopeial Convention Corporate Summary
Table 53. The United States Pharmacopeial Convention Eprosartan Mesylate Product Offerings
Table 54. The United States Pharmacopeial Convention Eprosartan Mesylate Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 55. Unichem Laboratories Corporate Summary
Table 56. Unichem Laboratories Eprosartan Mesylate Product Offerings
Table 57. Unichem Laboratories Eprosartan Mesylate Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 58. Jubilant Generics Corporate Summary
Table 59. Jubilant Generics Eprosartan Mesylate Product Offerings
Table 60. Jubilant Generics Eprosartan Mesylate Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 61. Eprosartan Mesylate Production Capacity (Tons) of Key Manufacturers in Global Market, 2020-2022 (Tons)
Table 62. Global Eprosartan Mesylate Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Eprosartan Mesylate Production by Region, 2017-2022 (Tons)
Table 64. Global Eprosartan Mesylate Production by Region, 2023-2028 (Tons)
Table 65. Eprosartan Mesylate Market Opportunities & Trends in Global Market
Table 66. Eprosartan Mesylate Market Drivers in Global Market
Table 67. Eprosartan Mesylate Market Restraints in Global Market
Table 68. Eprosartan Mesylate Raw Materials
Table 69. Eprosartan Mesylate Raw Materials Suppliers in Global Market
Table 70. Typical Eprosartan Mesylate Downstream
Table 71. Eprosartan Mesylate Downstream Clients in Global Market
Table 72. Eprosartan Mesylate Distributors and Sales Agents in Global Market
Table 1. Key Players of Eprosartan Mesylate in Global Market
Table 2. Top Eprosartan Mesylate Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Eprosartan Mesylate Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Eprosartan Mesylate Revenue Share by Companies, 2017-2022
Table 5. Global Eprosartan Mesylate Sales by Companies, (Tons), 2017-2022
Table 6. Global Eprosartan Mesylate Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Eprosartan Mesylate Price (2017-2022) & (US$/Ton)
Table 8. Global Manufacturers Eprosartan Mesylate Product Type
Table 9. List of Global Tier 1 Eprosartan Mesylate Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Eprosartan Mesylate Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Eprosartan Mesylate Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Eprosartan Mesylate Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Eprosartan Mesylate Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Eprosartan Mesylate Sales (Tons), 2017-2022
Table 15. By Type - Global Eprosartan Mesylate Sales (Tons), 2023-2028
Table 16. By Application – Global Eprosartan Mesylate Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Eprosartan Mesylate Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Eprosartan Mesylate Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Eprosartan Mesylate Sales (Tons), 2017-2022
Table 20. By Application - Global Eprosartan Mesylate Sales (Tons), 2023-2028
Table 21. By Region – Global Eprosartan Mesylate Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Eprosartan Mesylate Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Eprosartan Mesylate Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Eprosartan Mesylate Sales (Tons), 2017-2022
Table 25. By Region - Global Eprosartan Mesylate Sales (Tons), 2023-2028
Table 26. By Country - North America Eprosartan Mesylate Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Eprosartan Mesylate Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Eprosartan Mesylate Sales, (Tons), 2017-2022
Table 29. By Country - North America Eprosartan Mesylate Sales, (Tons), 2023-2028
Table 30. By Country - Europe Eprosartan Mesylate Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Eprosartan Mesylate Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Eprosartan Mesylate Sales, (Tons), 2017-2022
Table 33. By Country - Europe Eprosartan Mesylate Sales, (Tons), 2023-2028
Table 34. By Region - Asia Eprosartan Mesylate Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Eprosartan Mesylate Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Eprosartan Mesylate Sales, (Tons), 2017-2022
Table 37. By Region - Asia Eprosartan Mesylate Sales, (Tons), 2023-2028
Table 38. By Country - South America Eprosartan Mesylate Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Eprosartan Mesylate Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Eprosartan Mesylate Sales, (Tons), 2017-2022
Table 41. By Country - South America Eprosartan Mesylate Sales, (Tons), 2023-2028
Table 42. By Country - Middle East & Africa Eprosartan Mesylate Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Eprosartan Mesylate Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Eprosartan Mesylate Sales, (Tons), 2017-2022
Table 45. By Country - Middle East & Africa Eprosartan Mesylate Sales, (Tons), 2023-2028
Table 46. Abbott Corporate Summary
Table 47. Abbott Eprosartan Mesylate Product Offerings
Table 48. Abbott Eprosartan Mesylate Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 49. Viatris (Mylan) Corporate Summary
Table 50. Viatris (Mylan) Eprosartan Mesylate Product Offerings
Table 51. Viatris (Mylan) Eprosartan Mesylate Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 52. The United States Pharmacopeial Convention Corporate Summary
Table 53. The United States Pharmacopeial Convention Eprosartan Mesylate Product Offerings
Table 54. The United States Pharmacopeial Convention Eprosartan Mesylate Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 55. Unichem Laboratories Corporate Summary
Table 56. Unichem Laboratories Eprosartan Mesylate Product Offerings
Table 57. Unichem Laboratories Eprosartan Mesylate Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 58. Jubilant Generics Corporate Summary
Table 59. Jubilant Generics Eprosartan Mesylate Product Offerings
Table 60. Jubilant Generics Eprosartan Mesylate Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2017-2022)
Table 61. Eprosartan Mesylate Production Capacity (Tons) of Key Manufacturers in Global Market, 2020-2022 (Tons)
Table 62. Global Eprosartan Mesylate Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global Eprosartan Mesylate Production by Region, 2017-2022 (Tons)
Table 64. Global Eprosartan Mesylate Production by Region, 2023-2028 (Tons)
Table 65. Eprosartan Mesylate Market Opportunities & Trends in Global Market
Table 66. Eprosartan Mesylate Market Drivers in Global Market
Table 67. Eprosartan Mesylate Market Restraints in Global Market
Table 68. Eprosartan Mesylate Raw Materials
Table 69. Eprosartan Mesylate Raw Materials Suppliers in Global Market
Table 70. Typical Eprosartan Mesylate Downstream
Table 71. Eprosartan Mesylate Downstream Clients in Global Market
Table 72. Eprosartan Mesylate Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Eprosartan Mesylate Segment by Type
Figure 2. Eprosartan Mesylate Segment by Application
Figure 3. Global Eprosartan Mesylate Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Eprosartan Mesylate Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Eprosartan Mesylate Revenue, 2017-2028 (US$, Mn)
Figure 7. Eprosartan Mesylate Sales in Global Market: 2017-2028 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Eprosartan Mesylate Revenue in 2021
Figure 9. By Type - Global Eprosartan Mesylate Sales Market Share, 2017-2028
Figure 10. By Type - Global Eprosartan Mesylate Revenue Market Share, 2017-2028
Figure 11. By Type - Global Eprosartan Mesylate Price (US$/Ton), 2017-2028
Figure 12. By Application - Global Eprosartan Mesylate Sales Market Share, 2017-2028
Figure 13. By Application - Global Eprosartan Mesylate Revenue Market Share, 2017-2028
Figure 14. By Application - Global Eprosartan Mesylate Price (US$/Ton), 2017-2028
Figure 15. By Region - Global Eprosartan Mesylate Sales Market Share, 2017-2028
Figure 16. By Region - Global Eprosartan Mesylate Revenue Market Share, 2017-2028
Figure 17. By Country - North America Eprosartan Mesylate Revenue Market Share, 2017-2028
Figure 18. By Country - North America Eprosartan Mesylate Sales Market Share, 2017-2028
Figure 19. US Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Eprosartan Mesylate Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Eprosartan Mesylate Sales Market Share, 2017-2028
Figure 24. Germany Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 25. France Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Eprosartan Mesylate Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Eprosartan Mesylate Sales Market Share, 2017-2028
Figure 33. China Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 37. India Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Eprosartan Mesylate Revenue Market Share, 2017-2028
Figure 39. By Country - South America Eprosartan Mesylate Sales Market Share, 2017-2028
Figure 40. Brazil Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Eprosartan Mesylate Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Eprosartan Mesylate Sales Market Share, 2017-2028
Figure 44. Turkey Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 48. Global Eprosartan Mesylate Production Capacity (Tons), 2017-2028
Figure 49. The Percentage of Production Eprosartan Mesylate by Region, 2021 VS 2028
Figure 50. Eprosartan Mesylate Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Eprosartan Mesylate Segment by Type
Figure 2. Eprosartan Mesylate Segment by Application
Figure 3. Global Eprosartan Mesylate Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Eprosartan Mesylate Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Eprosartan Mesylate Revenue, 2017-2028 (US$, Mn)
Figure 7. Eprosartan Mesylate Sales in Global Market: 2017-2028 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Eprosartan Mesylate Revenue in 2021
Figure 9. By Type - Global Eprosartan Mesylate Sales Market Share, 2017-2028
Figure 10. By Type - Global Eprosartan Mesylate Revenue Market Share, 2017-2028
Figure 11. By Type - Global Eprosartan Mesylate Price (US$/Ton), 2017-2028
Figure 12. By Application - Global Eprosartan Mesylate Sales Market Share, 2017-2028
Figure 13. By Application - Global Eprosartan Mesylate Revenue Market Share, 2017-2028
Figure 14. By Application - Global Eprosartan Mesylate Price (US$/Ton), 2017-2028
Figure 15. By Region - Global Eprosartan Mesylate Sales Market Share, 2017-2028
Figure 16. By Region - Global Eprosartan Mesylate Revenue Market Share, 2017-2028
Figure 17. By Country - North America Eprosartan Mesylate Revenue Market Share, 2017-2028
Figure 18. By Country - North America Eprosartan Mesylate Sales Market Share, 2017-2028
Figure 19. US Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Eprosartan Mesylate Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Eprosartan Mesylate Sales Market Share, 2017-2028
Figure 24. Germany Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 25. France Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Eprosartan Mesylate Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Eprosartan Mesylate Sales Market Share, 2017-2028
Figure 33. China Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 37. India Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Eprosartan Mesylate Revenue Market Share, 2017-2028
Figure 39. By Country - South America Eprosartan Mesylate Sales Market Share, 2017-2028
Figure 40. Brazil Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Eprosartan Mesylate Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Eprosartan Mesylate Sales Market Share, 2017-2028
Figure 44. Turkey Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Eprosartan Mesylate Revenue, (US$, Mn), 2017-2028
Figure 48. Global Eprosartan Mesylate Production Capacity (Tons), 2017-2028
Figure 49. The Percentage of Production Eprosartan Mesylate by Region, 2021 VS 2028
Figure 50. Eprosartan Mesylate Industry Value Chain
Figure 51. Marketing Channels